These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 8655604

  • 21. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM, Roztocil E, Davies MG.
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [Abstract] [Full Text] [Related]

  • 22. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
    Kocic J, Bugarski D, Santibanez JF.
    Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
    [Abstract] [Full Text] [Related]

  • 23. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J, Schaefer B, Bechtel MJ, Kramer MD.
    Exp Cell Res; 1996 Feb 25; 223(1):91-101. PubMed ID: 8635500
    [Abstract] [Full Text] [Related]

  • 24. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF, Frontelo P, Iglesias M, Martínez J, Quintanilla M.
    J Cell Biochem; 1999 Jul 01; 74(1):61-73. PubMed ID: 10381262
    [Abstract] [Full Text] [Related]

  • 25. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
    Ghosh S, Brown R, Jones JC, Ellerbroek SM, Stack MS.
    J Biol Chem; 2000 Aug 04; 275(31):23869-76. PubMed ID: 10791952
    [Abstract] [Full Text] [Related]

  • 26. Augmented urokinase receptor expression in atheroma.
    Noda-Heiny H, Daugherty A, Sobel BE.
    Arterioscler Thromb Vasc Biol; 1995 Jan 04; 15(1):37-43. PubMed ID: 7749814
    [Abstract] [Full Text] [Related]

  • 27. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.
    Okada SS, Grobmyer SR, Barnathan ES.
    Arterioscler Thromb Vasc Biol; 1996 Oct 04; 16(10):1269-76. PubMed ID: 8857924
    [Abstract] [Full Text] [Related]

  • 28. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H, Sheng S.
    Cancer Res; 2001 Dec 15; 61(24):8676-82. PubMed ID: 11751384
    [Abstract] [Full Text] [Related]

  • 29. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
    Sliva D, English D, Lyons D, Lloyd FP.
    Biochem Biophys Res Commun; 2002 Jan 11; 290(1):552-7. PubMed ID: 11779207
    [Abstract] [Full Text] [Related]

  • 30. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes.
    Wakita H, Matsushita K, Nishimura K, Tokura Y, Furukawa F, Takigawa M.
    J Invest Dermatol; 1998 Mar 11; 110(3):253-8. PubMed ID: 9506444
    [Abstract] [Full Text] [Related]

  • 31. Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding.
    Watanabe M, Yano W, Kondo S, Hattori Y, Yamada N, Yanai R, Nishida T.
    Invest Ophthalmol Vis Sci; 2003 Aug 11; 44(8):3332-8. PubMed ID: 12882778
    [Abstract] [Full Text] [Related]

  • 32. The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.
    Padró T, Mesters RM, Dankbar B, Hintelmann H, Bieker R, Kiehl M, Berdel WE, Kienast J.
    J Cell Sci; 2002 May 01; 115(Pt 9):1961-71. PubMed ID: 11956327
    [Abstract] [Full Text] [Related]

  • 33. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
    Kobayashi H, Suzuki M, Kanayama N, Terao T.
    Clin Exp Metastasis; 2004 May 01; 21(2):159-66. PubMed ID: 15168733
    [Abstract] [Full Text] [Related]

  • 34. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.
    Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645
    [Abstract] [Full Text] [Related]

  • 35. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility.
    Nguyen DH, Hussaini IM, Gonias SL.
    J Biol Chem; 1998 Apr 03; 273(14):8502-7. PubMed ID: 9525964
    [Abstract] [Full Text] [Related]

  • 36. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
    Gualandris A, Presta M.
    J Cell Physiol; 1995 Mar 03; 162(3):400-9. PubMed ID: 7860647
    [Abstract] [Full Text] [Related]

  • 37. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
    Keski-Oja J, Koli K.
    J Invest Dermatol; 1992 Aug 03; 99(2):193-200. PubMed ID: 1629632
    [Abstract] [Full Text] [Related]

  • 38. Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor.
    Sandberg T, Ehinger A, Casslén B.
    J Clin Endocrinol Metab; 2001 Apr 03; 86(4):1724-30. PubMed ID: 11297609
    [Abstract] [Full Text] [Related]

  • 39. AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor.
    Schnickmann S, Camacho-Trullio D, Bissinger M, Eils R, Angel P, Schirmacher P, Szabowski A, Breuhahn K.
    J Invest Dermatol; 2009 May 03; 129(5):1140-8. PubMed ID: 19020551
    [Abstract] [Full Text] [Related]

  • 40. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM, Strickland S.
    J Cell Physiol; 1997 May 03; 171(2):217-25. PubMed ID: 9130470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.